Stocks · Health care · Biological Products, (No Diagnostic Substances)

DBV Technologies S.A.

DBVT Clue Score35
France Fiscal year ends December CIK 0001613780 Results filed 28 Oct 2026

What the insiders did Net buying

By person

10 insiders · 23 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Pharis Mohideen
Chief Medical Officer
—
$45.00K (16)
−$45.00K
144,531
$390.23K
+832.5%
Daniel B Soland
Director
$24.30K (1)
—
+$24.30K
20,000
$54.00K
+300.0%
Timothy E Morris
Director
$18.24K (1)
—
+$18.24K
12,000
$32.40K
—
Daniel Tasse
Chief Executive Officer
$14.19K (1)
—
+$14.19K
17,094
$46.15K
—
Adora Ndu
Director
$1.62K (1)
—
+$1.62K
1,825
$4.93K
—
Bpifrance EPIC
Member of 10% owner group
—
— (3)
$0.00
7,303,369
$19.72M
−31.6%
Baker Bros. Advisors LP entity
Director
—
—
—
14,575,984
$39.36M
+439.7%
Virginie Boucinha
Chief Financial Officer
—
—
—
70,000
$189.00K
—
Kevin Michael Trapp
Chief Commercial Officer
—
—
—
55,000
$148.50K
—
Sebastien Robitaille
Chief Financial Officer
—
—
—
36,500
$98.55K
+55.3%

No percentages here. This company's share count has moved by a factor of 2.2 over the window, from 136,948,872 to 296,061,497 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.